Schedule 13D ownership disclosure
MARINUS PHARMACEUTICALS INC
Security class unavailable · CUSIP: 56854Q101
Event date: 2016-11-15
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 601,584
- Percent of class
- 3.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-16-135851
- Form type
- SC 13D
- Filer
- MARINUS PHARMACEUTICALS, INC.
- CIK
- CIK 1267813
- Filed
- Nov 22, 2016
- Reporting period
- Nov 15, 2016
- Description
- Schedule 13D beneficial ownership